Compare FIS & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIS | A |
|---|---|---|
| Founded | 1968 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 39.8B |
| IPO Year | N/A | 1999 |
| Metric | FIS | A |
|---|---|---|
| Price | $67.26 | $138.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | $85.50 | ★ $162.80 |
| AVG Volume (30 Days) | ★ 2.7M | 2.2M |
| Earning Date | 02-10-2026 | 11-24-2025 |
| Dividend Yield | ★ 2.38% | 0.74% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | 0.29 | ★ 4.57 |
| Revenue | ★ $10,464,000,000.00 | $6,948,000,000.00 |
| Revenue This Year | $5.80 | $8.00 |
| Revenue Next Year | $4.55 | $6.29 |
| P/E Ratio | $200.47 | ★ $30.27 |
| Revenue Growth | 4.21 | ★ 6.73 |
| 52 Week Low | $59.51 | $96.43 |
| 52 Week High | $83.97 | $160.27 |
| Indicator | FIS | A |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 39.84 |
| Support Level | $65.36 | $136.23 |
| Resistance Level | $67.44 | $139.19 |
| Average True Range (ATR) | 1.14 | 2.54 |
| MACD | 0.06 | -0.63 |
| Stochastic Oscillator | 68.51 | 15.66 |
Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.